HEADER IMMUNE SYSTEM/VIRAL PROTEIN 01-JUN-12 4FFY TITLE CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TITLE 2 TO DENV-1 DIII, STRAIN 16007. COMPND MOL_ID: 1; COMPND 2 MOLECULE: DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT (LIGHT CHAIN); COMPND 3 CHAIN: L; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT (HEAVY CHAIN); COMPND 7 CHAIN: H; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: ENVELOPE GLYCOPROTEIN; COMPND 11 CHAIN: A; COMPND 12 FRAGMENT: UNP RESIDUES 573-679; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 STRAIN: IFN-ABR-/- C57BL/6 MICE; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PAK400; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 12 ORGANISM_TAXID: 10090; SOURCE 13 STRAIN: IFN-ABR-/- C57BL/6 MICE; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PAK400; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: DENGUE VIRUS 1; SOURCE 21 ORGANISM_TAXID: 11053; SOURCE 22 STRAIN: 16007; SOURCE 23 GENE: ENVELOPE DOMAIN III; SOURCE 24 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 26 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 27 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 28 EXPRESSION_SYSTEM_PLASMID: PET21A(+) KEYWDS VIRAL ENVELOPE PROTEINS, STRUCTURAL GENOMICS, ANTIBODY EPITOPES, KEYWDS 2 FLAVIVIRUS, DENGUE VIRUS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND KEYWDS 3 INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS KEYWDS 4 DISEASES, CSGID, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.K.AUSTIN,C.A.NELSON,D.H.FREMONT,CENTER FOR STRUCTURAL GENOMICS OF AUTHOR 2 INFECTIOUS DISEASES (CSGID) REVDAT 3 20-NOV-24 4FFY 1 REMARK SEQADV REVDAT 2 31-OCT-12 4FFY 1 JRNL REVDAT 1 20-JUN-12 4FFY 0 JRNL AUTH S.K.AUSTIN,K.A.DOWD,B.SHRESTHA,C.A.NELSON,M.A.EDELING, JRNL AUTH 2 S.JOHNSON,T.C.PIERSON,M.S.DIAMOND,D.H.FREMONT JRNL TITL STRUCTURAL BASIS OF DIFFERENTIAL NEUTRALIZATION OF DENV-1 JRNL TITL 2 GENOTYPES BY AN ANTIBODY THAT RECOGNIZES A CRYPTIC EPITOPE. JRNL REF PLOS PATHOG. V. 8 02930 2012 JRNL REFN ISSN 1553-7366 JRNL PMID 23055922 JRNL DOI 10.1371/JOURNAL.PPAT.1002930 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.3_928 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.35 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 17091 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 853 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.3611 - 4.5346 1.00 2908 152 0.1635 0.1959 REMARK 3 2 4.5346 - 3.5999 1.00 2787 147 0.1415 0.1983 REMARK 3 3 3.5999 - 3.1450 1.00 2726 144 0.1718 0.2491 REMARK 3 4 3.1450 - 2.8576 0.99 2702 142 0.1858 0.2522 REMARK 3 5 2.8576 - 2.6528 0.95 2568 129 0.2390 0.2893 REMARK 3 6 2.6528 - 2.4964 0.95 2547 139 0.3310 0.4608 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.98 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 43.36 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.410 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.85090 REMARK 3 B22 (A**2) : 0.85090 REMARK 3 B33 (A**2) : -1.70170 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2639 REMARK 3 ANGLE : 0.883 3580 REMARK 3 CHIRALITY : 0.060 386 REMARK 3 PLANARITY : 0.003 457 REMARK 3 DIHEDRAL : 12.746 944 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4FFY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1000072852. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-AUG-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.007 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17132 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.7800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.49400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.350 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.2M POTASSIUM SULFATE, REMARK 280 AND 5% GLYCEROL, PH 7.4, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 26.12500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 67.66500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 67.66500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.18750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 67.66500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 67.66500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 13.06250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 67.66500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 67.66500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.18750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 67.66500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 67.66500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 13.06250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 26.12500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY L 109 REMARK 465 GLY L 110 REMARK 465 GLY L 111 REMARK 465 SER L 112 REMARK 465 GLY L 113 REMARK 465 GLY L 114 REMARK 465 GLY L 115 REMARK 465 GLY L 116 REMARK 465 SER L 117 REMARK 465 GLY L 118 REMARK 465 GLY L 119 REMARK 465 GLY L 120 REMARK 465 GLY L 121 REMARK 465 SER L 122 REMARK 465 ALA H 120 REMARK 465 SER H 121 REMARK 465 GLY H 122 REMARK 465 ALA H 123 REMARK 465 ASP H 124 REMARK 465 HIS H 125 REMARK 465 HIS H 126 REMARK 465 HIS H 127 REMARK 465 HIS H 128 REMARK 465 HIS H 129 REMARK 465 HIS H 130 REMARK 465 MET A 289 REMARK 465 ALA A 290 REMARK 465 SER A 291 REMARK 465 MET A 292 REMARK 465 THR A 293 REMARK 465 LEU A 294 REMARK 465 LYS A 295 REMARK 465 GLY A 296 REMARK 465 MET A 297 REMARK 465 SER A 298 REMARK 465 SER A 396 REMARK 465 SER A 397 REMARK 465 ILE A 398 REMARK 465 GLY A 399 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 51 -41.75 72.88 REMARK 500 GLU L 68 -84.91 59.17 REMARK 500 TRP H 103 -101.18 -109.77 REMARK 500 ALA A 354 -78.97 -51.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL L 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL L 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL L 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL L 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 H 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL H 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3IRC RELATED DB: PDB REMARK 900 DENGUE-1 ENVELOPE PROTEIN DOMAIN III. REMARK 900 RELATED ID: 4FFZ RELATED DB: PDB REMARK 900 RELATED ID: IDP00272 RELATED DB: TARGETTRACK DBREF 4FFY A 293 399 UNP Q9J7C6 Q9J7C6_9FLAV 573 679 DBREF 4FFY L 1 122 PDB 4FFY 4FFY 1 122 DBREF 4FFY H 1 130 PDB 4FFY 4FFY 1 130 SEQADV 4FFY MET A 289 UNP Q9J7C6 EXPRESSION TAG SEQADV 4FFY ALA A 290 UNP Q9J7C6 EXPRESSION TAG SEQADV 4FFY SER A 291 UNP Q9J7C6 EXPRESSION TAG SEQADV 4FFY MET A 292 UNP Q9J7C6 EXPRESSION TAG SEQRES 1 L 126 ASN ILE VAL LEU THR GLN SER PRO ALA SER LEU ALA VAL SEQRES 2 L 126 SER LEU GLY GLN ARG ALA THR ILE SER CYS ARG ALA SER SEQRES 3 L 126 GLU SER VAL ASP HIS TYR GLY ASN SER PHE ILE TYR TRP SEQRES 4 L 126 TYR GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU LEU ILE SEQRES 5 L 126 TYR LEU ALA SER ASN LEU GLU SER GLY VAL PRO ALA ARG SEQRES 6 L 126 PHE SER GLY SER GLY SER GLU THR ASP PHE THR LEU THR SEQRES 7 L 126 ILE ASP SER VAL GLU THR ASP ASP ALA ALA THR TYR TYR SEQRES 8 L 126 CYS GLN GLN ASN ASN GLU ASP PRO TYR THR PHE GLY GLY SEQRES 9 L 126 GLY THR LYS LEU GLU ILE LYS GLY GLY GLY GLY SER GLY SEQRES 10 L 126 GLY GLY GLY SER GLY GLY GLY GLY SER SEQRES 1 H 130 GLN VAL GLN LEU LEU GLN PRO GLY ALA GLU LEU VAL LYS SEQRES 2 H 130 PRO GLY ALA SER MET LYS LEU SER CYS LYS ALA SER GLY SEQRES 3 H 130 TYR THR PHE THR ASN TRP TRP MET HIS TRP VAL ARG LEU SEQRES 4 H 130 ARG PRO GLY ARG GLY LEU GLU TRP ILE GLY ARG ILE ASP SEQRES 5 H 130 PRO ASN SER ASP VAL ASN LYS TYR ASN GLU LYS PHE GLU SEQRES 6 H 130 ASN ARG ALA SER LEU THR VAL ASP LYS HIS SER SER THR SEQRES 7 H 130 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 H 130 ALA ILE TYR TYR CYS ALA ARG TRP PHE PHE PRO TRP TYR SEQRES 9 H 130 PHE ASP VAL TRP GLY THR GLY THR THR VAL THR VAL SER SEQRES 10 H 130 SER ALA ALA SER GLY ALA ASP HIS HIS HIS HIS HIS HIS SEQRES 1 A 111 MET ALA SER MET THR LEU LYS GLY MET SER TYR VAL MET SEQRES 2 A 111 CYS THR GLY SER PHE LYS LEU GLU LYS GLU VAL ALA GLU SEQRES 3 A 111 THR GLN HIS GLY THR VAL LEU VAL GLN VAL LYS TYR GLU SEQRES 4 A 111 GLY THR ASP ALA PRO CYS LYS ILE PRO PHE SER THR GLN SEQRES 5 A 111 ASP GLU LYS GLY ALA THR GLN ASN GLY ARG LEU ILE THR SEQRES 6 A 111 ALA ASN PRO ILE VAL THR ASP LYS GLU LYS PRO VAL ASN SEQRES 7 A 111 ILE GLU ALA GLU PRO PRO PHE GLY GLU SER TYR ILE VAL SEQRES 8 A 111 VAL GLY ALA GLY GLU LYS ALA LEU LYS LEU SER TRP PHE SEQRES 9 A 111 LYS LYS GLY SER SER ILE GLY HET GOL L 301 6 HET CL L 302 1 HET CL L 303 1 HET CL L 304 1 HET SO4 H 201 5 HET CL H 202 1 HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 GOL C3 H8 O3 FORMUL 5 CL 4(CL 1-) FORMUL 8 SO4 O4 S 2- FORMUL 10 HOH *138(H2 O) HELIX 1 1 GLU L 79 ALA L 83 5 5 HELIX 2 2 THR H 28 TRP H 32 5 5 HELIX 3 3 THR H 87 SER H 91 5 5 SHEET 1 A 4 LEU L 4 SER L 7 0 SHEET 2 A 4 ALA L 19 ALA L 25 -1 O ARG L 24 N THR L 5 SHEET 3 A 4 ASP L 70 ILE L 75 -1 O LEU L 73 N ILE L 21 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 63 O THR L 74 SHEET 1 B 6 SER L 10 SER L 14 0 SHEET 2 B 6 THR L 102 LYS L 107 1 O GLU L 105 N LEU L 11 SHEET 3 B 6 ALA L 84 GLN L 90 -1 N ALA L 84 O LEU L 104 SHEET 4 B 6 ILE L 33 GLN L 38 -1 N TYR L 36 O TYR L 87 SHEET 5 B 6 LYS L 45 TYR L 49 -1 O LEU L 47 N TRP L 35 SHEET 6 B 6 ASN L 53 LEU L 54 -1 O ASN L 53 N TYR L 49 SHEET 1 C 4 SER L 10 SER L 14 0 SHEET 2 C 4 THR L 102 LYS L 107 1 O GLU L 105 N LEU L 11 SHEET 3 C 4 ALA L 84 GLN L 90 -1 N ALA L 84 O LEU L 104 SHEET 4 C 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 D 2 ASP L 30 HIS L 30A 0 SHEET 2 D 2 ASN L 30D SER L 31 -1 O ASN L 30D N HIS L 30A SHEET 1 E 4 GLN H 3 LEU H 5 0 SHEET 2 E 4 MET H 18 SER H 25 -1 O LYS H 23 N LEU H 5 SHEET 3 E 4 THR H 78 LEU H 83 -1 O MET H 81 N LEU H 20 SHEET 4 E 4 ALA H 68 ASP H 73 -1 N THR H 71 O TYR H 80 SHEET 1 F 6 ALA H 9 VAL H 12 0 SHEET 2 F 6 THR H 112 VAL H 116 1 O THR H 115 N GLU H 10 SHEET 3 F 6 ALA H 92 TRP H 99 -1 N ALA H 92 O VAL H 114 SHEET 4 F 6 MET H 34 ARG H 40 -1 N VAL H 37 O TYR H 95 SHEET 5 F 6 GLY H 44 ILE H 51 -1 O ILE H 48 N TRP H 36 SHEET 6 F 6 ASN H 58 TYR H 60 -1 O LYS H 59 N ARG H 50 SHEET 1 G 4 ALA H 9 VAL H 12 0 SHEET 2 G 4 THR H 112 VAL H 116 1 O THR H 115 N GLU H 10 SHEET 3 G 4 ALA H 92 TRP H 99 -1 N ALA H 92 O VAL H 114 SHEET 4 G 4 PHE H 105 TRP H 108 -1 O VAL H 107 N ARG H 98 SHEET 1 H 3 SER A 305 LEU A 308 0 SHEET 2 H 3 VAL A 320 GLU A 327 -1 O LYS A 325 N LYS A 307 SHEET 3 H 3 ALA A 313 GLU A 314 -1 N ALA A 313 O LEU A 321 SHEET 1 I 4 SER A 305 LEU A 308 0 SHEET 2 I 4 VAL A 320 GLU A 327 -1 O LYS A 325 N LYS A 307 SHEET 3 I 4 VAL A 365 GLU A 370 -1 O ILE A 367 N VAL A 322 SHEET 4 I 4 ARG A 350 LEU A 351 -1 N ARG A 350 O GLU A 370 SHEET 1 J 2 CYS A 333 LYS A 334 0 SHEET 2 J 2 ILE A 357 VAL A 358 -1 O VAL A 358 N CYS A 333 SHEET 1 K 3 PHE A 337 GLN A 340 0 SHEET 2 K 3 GLY A 374 VAL A 380 -1 O VAL A 379 N SER A 338 SHEET 3 K 3 LEU A 387 LYS A 393 -1 O LEU A 389 N ILE A 378 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.05 SSBOND 2 CYS H 22 CYS H 96 1555 1555 2.04 SSBOND 3 CYS A 302 CYS A 333 1555 1555 2.04 CISPEP 1 SER L 7 PRO L 8 0 -1.18 CISPEP 2 ASP L 94 PRO L 95 0 -2.37 CISPEP 3 PHE H 101 PRO H 102 0 -3.17 CISPEP 4 ALA A 331 PRO A 332 0 2.32 SITE 1 AC1 7 GLN L 37 LYS L 45 PRO L 59 PHE L 62 SITE 2 AC1 7 ASP L 81 ASP L 82 CL L 304 SITE 1 AC2 2 LYS L 39 HOH L 455 SITE 1 AC3 2 TYR H 95 HOH L 412 SITE 1 AC4 3 ARG L 61 ASP L 81 GOL L 301 SITE 1 AC5 5 GLU A 384 TYR H 27 THR H 28 ASN H 31 SITE 2 AC5 5 TRP H 32 SITE 1 AC6 3 ASP H 73 LYS H 74 HOH H 336 CRYST1 135.330 135.330 52.250 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007389 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007389 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019139 0.00000